TCI GENE Statistics

Total Valuation

TCI GENE has a market cap or net worth of TWD 881.07 million. The enterprise value is 30.20 million.

Market Cap	881.07M
Enterprise Value	30.20M

Important Dates

The next estimated earnings date is Thursday, March 12, 2026.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	Sep 5, 2025

Share Statistics

TCI GENE has 26.46 million shares outstanding. The number of shares has increased by 0.20% in one year.

Current Share Class	26.46M
Shares Outstanding	26.46M
Shares Change (YoY)	+0.20%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	9.82%
Owned by Institutions (%)	1.71%
Float	4.33M

Valuation Ratios

The trailing PE ratio is 24.66.

PE Ratio	24.66
Forward PE	n/a
PS Ratio	2.71
PB Ratio	0.95
P/TBV Ratio	0.97
P/FCF Ratio	9.32
P/OCF Ratio	9.07
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 0.52, with an EV/FCF ratio of 0.32.

EV / Earnings	0.84
EV / Sales	0.09
EV / EBITDA	0.52
EV / EBIT	0.67
EV / FCF	0.32

Financial Position

The company has a current ratio of 5.74, with a Debt / Equity ratio of 0.01.

Current Ratio	5.74
Quick Ratio	5.47
Debt / Equity	0.01
Debt / EBITDA	0.19
Debt / FCF	0.13
Interest Coverage	64.06

Financial Efficiency

Return on equity (ROE) is 3.42% and return on invested capital (ROIC) is 78.84%.

Return on Equity (ROE)	3.42%
Return on Assets (ROA)	2.97%
Return on Invested Capital (ROIC)	78.84%
Return on Capital Employed (ROCE)	5.95%
Weighted Average Cost of Capital (WACC)	5.20%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.28
Inventory Turnover	3.16

Taxes

In the past 12 months, TCI GENE has paid 7.95 million in taxes.

Income Tax	7.95M
Effective Tax Rate	18.91%

Stock Price Statistics

The stock price has decreased by -36.57% in the last 52 weeks. The beta is 0.17, so TCI GENE's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	-36.57%
50-Day Moving Average	36.28
200-Day Moving Average	40.29
Relative Strength Index (RSI)	34.53
Average Volume (20 Days)	6,788

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TCI GENE had revenue of TWD 324.73 million and earned 35.80 million in profits. Earnings per share was 1.35.

Revenue	324.73M
Gross Profit	186.94M
Operating Income	55.42M
Pretax Income	42.03M
Net Income	35.80M
EBITDA	61.93M
EBIT	55.42M
Earnings Per Share (EPS)	1.35

Full Income Statement

Balance Sheet

The company has 883.95 million in cash and 12.57 million in debt, giving a net cash position of 871.39 million or 32.93 per share.

Cash & Cash Equivalents	883.95M
Total Debt	12.57M
Net Cash	871.39M
Net Cash Per Share	32.93
Equity (Book Value)	928.38M
Book Value Per Share	34.31
Working Capital	830.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 97.15 million and capital expenditures -2.61 million, giving a free cash flow of 94.55 million.

Operating Cash Flow	97.15M
Capital Expenditures	-2.61M
Free Cash Flow	94.55M
FCF Per Share	3.57

Full Cash Flow Statement

Margins

Gross margin is 57.57%, with operating and profit margins of 17.07% and 11.02%.

Gross Margin	57.57%
Operating Margin	17.07%
Pretax Margin	12.94%
Profit Margin	11.02%
EBITDA Margin	19.07%
EBIT Margin	17.07%
FCF Margin	29.12%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 5.57%.

Dividend Per Share	2.00
Dividend Yield	5.57%
Dividend Growth (YoY)	-33.33%
Years of Dividend Growth	1
Payout Ratio	73.91%
Buyback Yield	-0.20%
Shareholder Yield	5.38%
Earnings Yield	4.06%
FCF Yield	10.73%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TCI GENE has an Altman Z-Score of 6.35 and a Piotroski F-Score of 4.

Altman Z-Score	6.35
Piotroski F-Score	4